We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Global Minimally Invasive Surgical Devices Market to Reach USD 28.5 Billion by 2026 Due to Need for Lesser Complications in Surgeries

By HospiMedica International staff writers
Posted on 08 Feb 2022
Illustration
Illustration

The global minimally invasive surgical devices market is projected to grow at a CAGR of 5.56% from USD 20.93 billion in 2020 to USD 28.54 billion by 2026, driven mainly by the increasing preference for minimally invasive surgeries to avoid physical scar marks and painful recovery, and increasing instances of prolonged & chronic diseases such as cardiovascular diseases, neurological diseases, cancer, etc., where surgeries are a must as a treatment method.

These are the latest findings of Research and Markets (Dublin, Ireland), a market research company.

Minimally invasive devices are technologically advanced and require rather small entry points to enter the human body. Complications of surgeries like cancer removal surgeries, endoscopic surgeries, cardiovascular surgeries, etc. has also increased preference among surgeons for minimally invasive surgeries in order to avoid mistakes, post op-pain for patient, over bleeding, or other complications. Furthermore, increased investment in the healthcare sector, consistent research and development of innovative medical devices by multiple market players are further driving market growth.

However, technological advancements in existing medical devices demands financial and research investments from the market players, and the manufactured medical devices are also required to obtain approvals through clinical trials before being commercialized and utilized for patient treatment, that may restrain market growth.

Based on type, the handheld instruments segment is anticipated to hold the largest revenue share of the minimally invasive surgical devices market and maintain a dominant position on account of increasing demand for precision during surgeries. Moreover, a surge in the demand for technologically-advanced surgical devices like graspers, retractors, and elevators is also expected to support market growth.

Related Links:
Research and Markets 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more